Neuralstem, Inc. News Headlines

CUR 
$1.4
*  
0.04
  negative  
2.78%
Get CUR Alerts
*Delayed - data as of May 24, 2013 
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Neuralstem Phase I Results Encourage Market, Stimulate Buying
5/22/2013 7:33:00 AM - Seeking Alpha

Neuralstem: Update On Phase I Trial Of Neural Stem Cells In ALS Is Encouraging
5/21/2013 8:18:13 AM - SeekingAlpha

A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013
5/20/2013 11:38:00 AM - Seeking Alpha

SmithOnStocks Opines On Stocks: May 19th Edition
5/19/2013 8:32:00 PM - Seeking Alpha

Neuralstem: Update On ALS Trial Could Be A Catalyst For The Stock
5/16/2013 9:55:00 AM - Seeking Alpha

Neuralstem Rounding Second With Phase II ALS Trial
5/16/2013 7:56:00 AM - Seeking Alpha

ACT, THRX Hit All-time High, NSPH Makes A Big Move, BTX Gets Funding
5/13/2013 10:08:00 PM - RTT News

SmithOnStocks Opines On Recent Biotech News
5/13/2013 5:38:00 AM - Seeking Alpha

Neuralstem Q1 Loss Widens - Quick Facts
5/10/2013 4:58:00 PM - RTT News

5 Stocks Under $10 Set to Soar
5/9/2013 1:49:00 PM - TheStreet

Neuralstem: Anticipating More Efficacy Data From ALS Trial And Update On New Clinical Trials
5/7/2013 2:07:29 PM - SeekingAlpha

StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company
5/2/2013 8:11:00 AM - Seeking Alpha

Stem Cells: Invest At Your Own Peril
5/1/2013 5:33:00 AM - Seeking Alpha

Regenerative Medicine's Time Has Come
4/28/2013 1:34:00 AM - Seeking Alpha

SSRX' Revised Go-private Offer, Red Flag For IBIO, TTNP, VPHM To Watch Out For
4/22/2013 11:21:00 PM - RTT News

Neuralstem To Begin Dosing Final Cohort Of Patients In NSI-189 Phase Ib Trial
4/22/2013 9:27:00 AM - RTT News

2 Biotech Stocks Announcing Key Early Stage Clinical Developments
4/17/2013 2:22:00 PM - Seeking Alpha

Investing In The Stem Cell Sector: An Overview
4/17/2013 8:36:00 AM - Seeking Alpha

Neuralstem Obtains FDA Approval To Begin Phase II Stem Cell Trial In ALS
4/17/2013 8:11:00 AM - RTT News

The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
4/10/2013 4:00:00 AM - Seeking Alpha

Updating A Speculative Idea And Sharing A New One
4/1/2013 12:36:00 PM - Seeking Alpha

Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy
3/28/2013 9:14:00 AM - Seeking Alpha

Buy Hercules Tech Growth Capital Instead Of OCZ Tech
3/27/2013 6:35:00 AM - Seeking Alpha

The Future Of Medicine: A Look At 5 Stem Cell Companies
3/22/2013 11:58:00 AM - Seeking Alpha

Neuralstem Update Fails To Excite, All Eyes On Upcoming Phase II Trial
3/21/2013 12:23:00 PM - Seeking Alpha